THE LATEST WORD

Top Industry Stories- November 12, 2009

Posted on November 12th, 2009 | by Rxmedyn | No Comments »

A Gem In Cephalon’s Pipeline? Cinquil Offers The Promise Of A Boost (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Bayer to up R&D spend as Higgins looks to the future (PharmaTimes.com)

Pfizer critical of “selective outcome reporting” study (PharmaTimes.com)

Read the rest of this entry »

Top Industry Stories-November 11,2009

Posted on November 11th, 2009 | by Rxmedyn | No Comments »
 

 NeuroTherapeutics Pharma Receives Investment From The Epilepsy Therapy Project (Medical News Today)

Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab (Medical News Today)

Read the rest of this entry »

Top Industry Stories- November 10, 2009

Posted on November 10th, 2009 | by Rxmedyn | No Comments »
Pfizer sheds six facilities in R&D shake-up (PharmaTimes.com)

PhRMA’s Web Search Solution: Add Icon Or Generic Risk Statement In Results (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Read the rest of this entry »

Top Industry Stories-November 9,2009

Posted on November 9th, 2009 | by Rxmedyn | No Comments »

Medicis to Present at Credit Suisse Annual Healthcare Conference (Medicis.com)

Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer’s Disease (Pharmalive.com)

Good news for GSK’s Synflorix, FDA review of RLS drug put back (PharmaTimes.com)

Read the rest of this entry »

Top Industry Stories- November 6, 2009

Posted on November 6th, 2009 | by Rxmedyn | No Comments »

Kellogg To Stop Immunity Clamis On Rice Krispies, US (Medical News Today)

Less Brain Injury For Infants Starved Of Oxygen At Birth With Therapeutic Cooling And Accurate MRI Prognosis (TOBY Trial) (Medical News Today)

New Statement Outlines ATS Positions On Research, Education, Advocacy (Medical News Today)

Read the rest of this entry »

Top Industry Stories-November 5, 2009

Posted on November 5th, 2009 | by Rxmedyn | No Comments »

Boerhinger Ingelheim’s Phase II Agent Could Be The First Second-Wave Protease Inhibitor For Hep C (Health News Daily)

Panel Rejects Zimmer’s Dynesys Spine Stabilization Device PMA, Faults Data(Health News Daily)

Merged House Bill Seeks More Part D Savings, Broader Medicaid Expansion(The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Read the rest of this entry »

Top Industry Stories November 4, 2009

Posted on November 4th, 2009 | by Rxmedyn | No Comments »

“Medco Predicts Public Health Plan’s Drug Benefit Will Be Outsourced”(The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

“Hospital Fined for Wrong-Site Surgery” (MedPage Today)

“US H1N1 Swine Flu Vaccine Supply On Track To Hit 10 Million Increase Says CDC Director” (Medical News Today)

Read the rest of this entry »

Top Industry Stories – November 3, 2009

Posted on November 3rd, 2009 | by Rxmedyn | No Comments »

“FDA Okays Diabetes Drug for First-Line Use, Adds Warning”

 

Read the rest of this entry »

Top Industry Stories – November 2, 2009

Posted on November 2nd, 2009 | by Rxmedyn | No Comments »

“Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies” (Shering-Plough Release)
“Abbott Completes Acquisition of Evalve, Inc.” (Press release from Abbott)

“BRIEF-GlaxoSmithKline, Valeant file Retigabine with FDA” (Reuters)

Read the rest of this entry »